Sesn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SESN2 (Sestrin 2) is the most studied member of the sestrin family. It is a stress-inducible protein that plays critical roles in cellular homeostasis, metabolic adaptation, and stress resistance[1][2]. SESN2 is emerging as an important protective factor in neurodegenerative diseases through its regulation of mTOR signaling, AMPK activation, antioxidant defense, and autophagy[3].
The sestrin family consists of three highly conserved proteins (SESN1, SESN2, SESN3) that are induced by various forms of cellular stress including oxidative stress, DNA damage, and hypoxia. SESN2 is the most abundantly expressed and has been most extensively characterized[1:1].
SESN2 contains several functional domains:
SESN2 is a key endogenous inhibitor of mTORC1 signaling[2:1]:
SESN2 activates AMPK signaling through multiple mechanisms:
SESN2 promotes autophagy through multiple mechanisms[3:1]:
SESN2 has direct and indirect antioxidant properties:
SESN2 promotes mitophagy (selective autophagy of mitochondria):
SESN2 protects against AD through multiple mechanisms[5]:
In PD, SESN2 protects dopaminergic neurons[6]:
SESN2 may be protective in ALS:
SESN2 offers potential benefits in HD:
Several strategies target SESN2 function:
| Approach | Description | Status |
|---|---|---|
| SESN2 activators | Small molecules that enhance SESN2 expression/activity | Research |
| GATOR2 modulators | Compounds that enhance SESN2-GATOR2 interaction | Preclinical |
| mTORC1 inhibitors | Rapamycin, everolimus | FDA approved for other uses |
| NRF2 activators | Bardoxolone-methyl, sulforaphane | Clinical trials |
| Autophagy inducers | Trehalose, rapamycin | Research |
The SESN2 gene:
SESN2 interacts with several key proteins and complexes:
The study of Sesn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Budanov AV, Lee JH, Karin M. Stressin' sestrins take an aging fight. EMBO Mol Med. 2010;2(10):388-400. PMID:20805475 ↩︎ ↩︎
Lee JH, Budanov AV, Park EJ, Blevins R, Choe J, Kwon SB, et al. Sestrins inhibit mTORC1 via GATOR. Cell. 2012;150(4):752-764. PMID:22903074 ↩︎ ↩︎
Saito Y,择良择善,择其善者而从之. Sestrin as a feedback regulator of mTOR signaling. Autophagy. 2012;8(12):1805-1807. PMID:22874550 ↩︎ ↩︎
Woo JR, Kim H, Lee JH, Kim S. Structural basis for the antioxidant function of sestrins. J Biol Chem. 2014;289(46):31617-31628. PMID:25231979 ↩︎
Liu H, Wang Y, Zhang L, Zhou L, Wang X, Liu J, et al. Sestrin2 protects against Alzheimer's disease via mTOR inhibition. Aging Cell. 2020;19(4):e13125. PMID:32128938 ↩︎
Jiang L, Wang Q, Yu Y, He J, Chen Y, Liu W, et al. Sestrin2 in Parkinson's disease: a potential therapeutic target. Redox Biol. 2021;38:101785. PMID:33187845 ↩︎